Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Inmune Bio, Inc. has filed 590 SEC EDGAR filings since 13 Jul 2017

SEC filing history

Showing 301-325 of 590 matching filings.

Per page
25
Current page
13
8-K File 001-38793

CURRENT REPORT

Filing date
22 Sep 2021
Reporting date
20 Sep 2021
Next action
Verify source filing
424B3 File 333-259368

PROSPECTUS

Filing date
21 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259368

EFFECT filing

Filing date
17 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
15 Sep 2021
Reporting date
13 Sep 2021
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
08 Sep 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
08 Sep 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
07 Sep 2021
Reporting date
07 Sep 2021
Next action
Verify source filing
S-3 File 333-259368

REGISTRATION STATEMENT

Filing date
07 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
Next action
Verify source filing
4

4 filing

Filing date
27 Aug 2021
Reporting date
25 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
26 Aug 2021
Reporting date
25 Aug 2021
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
23 Aug 2021
Reporting date
23 Aug 2021
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
12 Aug 2021
Reporting date
10 Aug 2021
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
06 Aug 2021
Reporting date
04 Aug 2021
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
05 Aug 2021
Reporting date
04 Aug 2021
Next action
Verify source filing
10-Q File 001-38793

QUARTERLY REPORT

Filing date
04 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
04 Aug 2021
Reporting date
04 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
29 Jul 2021
Reporting date
28 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
27 Jul 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
20 Jul 2021
Reporting date
19 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90859

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
19 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .